Celltrion
068270.KS
#794
Rank
ยฃ21.99 B
Marketcap
ยฃ100.55
Share price
0.00%
Change (1 day)
5.06%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): ยฃ1.42

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ1.42. In 2024 the company made an earnings per share (EPS) of ยฃ1.01 a decrease over its 2023 EPS that were of ยฃ1.99.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ1.4240.9%
2024ยฃ1.01-49.57%
2023ยฃ1.99-2.08%
2022ยฃ2.04-11.72%
2021ยฃ2.312.03%
2020ยฃ2.2682.8%
2019ยฃ1.2418.31%
2018ยฃ1.05-36.33%
2017ยฃ1.64161.25%
2016ยฃ0.632.86%
2015ยฃ0.6117.84%
2014ยฃ0.525.87%
2013ยฃ0.49-70.85%
2012ยฃ1.68134.09%
2011ยฃ0.7243.59%
2010ยฃ0.5074.49%
2009ยฃ0.29317.8%
2008ยฃ0.06856-71.7%
2007ยฃ0.24